Pharmacist & Inquiry Support: 385.279.4420 | Fax: 385.855.1221 | pharmacy@genesiscompounding.com

EXO ELEVATE Skin Longevity Complex

EXO ELEVATE Skin Longevity Complex is used in prescriber-directed longevity, peptide, antioxidant, or skin-longevity protocols. Published evidence varies substantially by ingredient, so the page avoids unsupported disease-treatment claims.

CreamTopicalRx Only503A Compounded

EXO ELEVATE Skin Longevity Complex is a compounded topical preparation formulated for prescriber-directed use in advanced skin anti-aging protocols. It combines an extracellular vesicle (exosome) complex with longevity-supporting bioactive ingredients — which may include peptides, antioxidants, or growth factors — to target multiple hallmarks of skin aging: cellular senescence, loss of dermal extracellular matrix integrity, chronic low-grade inflammation (inflammaging), and impaired skin barrier function. Genesis Compounding prepares this as a prescription-only, patient-specific 503A compounded preparation; it is not FDA-approved as a compounded product.

Active IngredientPharmacologic Role
Exosome/Extracellular Vesicle Complex (EXO ELEVATE proprietary blend)Mesenchymal stem cell- or plant-derived extracellular vesicles that deliver growth factors (VEGF, TGF-β, FGF), anti-senescence miRNAs, and anti-inflammatory cytokines to aging dermal fibroblasts and epidermal keratinocytes, addressing cellular senescence and extracellular matrix degradation.

Route: Topical application to facial or target skin areas.

Apply a thin, even layer to freshly cleansed and toned skin. Gently press or massage into the skin until fully absorbed. May be used morning, evening, or both as directed by the prescribing clinician. Follow with a broad-spectrum SPF ≥30 sunscreen during daytime use. Avoid contact with eyes and mucous membranes. For enhanced penetration, application following appropriate energy-based procedures (microneedling, radiofrequency) may be coordinated with the treating clinician.

Application protocol is prescriber-directed based on the patient's skin aging presentation and co-interventions. Typical practice:

  • Apply once or twice daily to targeted areas.
  • Systematic assessment of response is recommended after 8–12 weeks of consistent use.
  • Coordinate application timing with any concurrent topical retinoids, acids, or procedural treatments as directed.

Extracellular vesicles in EXO ELEVATE target key mechanisms of skin aging through their bioactive cargo:

  • Anti-senescence signaling: miRNAs delivered by exosomes downregulate senescence-associated secretory phenotype (SASP) markers (IL-6, IL-8, MMP-1), reducing chronic inflammatory signaling from senescent dermal fibroblasts that degrades surrounding ECM.
  • ECM restoration: Growth factors (TGF-β, PDGF, FGF) stimulate fibroblast proliferation and collagen I/III, elastin, and hyaluronan synthesis, restoring dermal structural integrity and viscoelasticity.
  • Antioxidant delivery: Vesicle-encapsulated antioxidant enzymes and cargo reduce reactive oxygen species that drive both photoaging and replicative senescence.
  • Epidermal regeneration: EGF-like growth factors within the vesicle cargo support keratinocyte proliferation and accelerate turnover, improving skin surface texture and renewal.

Clinical Context: EXO ELEVATE is designed for use in prescriber-directed longevity dermatology — a growing clinical subspecialty focused on slowing and reversing biological skin aging at the cellular level. Target patients include those with photoaged skin, significant facial rhytides, loss of skin density, or patients seeking comprehensive skin aging prevention as part of a longevity medicine protocol. The exosome platform addresses aging from a systems biology perspective, targeting multiple aging pathways simultaneously.

Monitoring Considerations:

  • Baseline and follow-up dermatological photography, skin analyzer measurements (hydration, elasticity, trans-epidermal water loss), and patient-reported outcomes are recommended.
  • Coordinate with any concurrent oral longevity interventions or systemic anti-aging protocols to ensure compatibility.

Contraindications:

  • Known hypersensitivity to any component of the preparation.
  • Active inflammatory skin conditions or cutaneous infection at the application site.

Warnings & Precautions:

  • For topical use only. Avoid ocular and mucosal contact.
  • Evidence base for topical exosome longevity preparations is still emerging; prescribers should discuss realistic expectations with patients.

Drug Interactions:

  • Strong topical oxidants applied simultaneously may degrade vesicle integrity; separate application as directed.

Common Side Effects: Minimal. Transient mild erythema or tingling may occur, particularly post-procedure. Generally well tolerated across skin types.

Refrigerate at 2–8°C (36–46°F) to preserve extracellular vesicle bioactivity unless label specifies otherwise. Protect from light and freezing. Keep out of reach of children. Use before the BUD assigned by Genesis Compounding.

What does 'skin longevity' mean in the context of this preparation?

Skin longevity refers to interventions that target the biological mechanisms of skin aging — cellular senescence, inflammation, oxidative stress, and ECM degradation — rather than only addressing superficial appearance. EXO ELEVATE aims to modulate these underlying processes with exosome-delivered regenerative signals.

How does this differ from standard anti-aging creams?

Conventional anti-aging products typically contain antioxidants, peptides, or retinoids that work through surface-level biochemistry. EXO ELEVATE uses extracellular vesicles — biological nanoparticles — to deliver actual cell-signaling molecules that interact with fibroblasts and keratinocytes at a genetic level, addressing multiple aging pathways simultaneously.

Is this FDA-approved?

No. This is a prescription-only 503A compounded preparation made by Genesis Compounding to your prescriber's order. It is not an FDA-approved drug product.

Can I use this alongside retinoids?

Many longevity skin protocols combine exosome preparations with topical retinoids. Your prescriber will advise on sequencing and timing to maximize benefits while minimizing potential for skin irritation.

How long will I need to use this?

Skin aging is a continuous process, and longevity interventions typically require ongoing use to maintain benefit. Your prescriber will establish a treatment plan with defined assessment intervals and may adjust the regimen based on your response.

Clinical References

Authoritative sources reviewed in preparing this clinical summary. Provided for prescriber reference; not a substitute for the prescriber’s clinical judgment.

Effectiveness of Extracellular Vesicle Application in Skin Aging — PMC IJMS
International Journal of Molecular Sciences / PMC, 2025
Source →
Exosomes in Skin Rejuvenation: Systematic Review
Dermatology Practical & Conceptual, 2026
Source →
Regenerative and Protective Actions of the GHK-Cu Peptide in Skin — PMC IJMS
Pickart L, Margolina A., IJMS / PMC, 2018
Source →